EPTIS
BAM Logo

IQ-15 Anti TNF therapy monitoring

[Monitorización de terapias anti TNF]

EPTIS factsheet 288072 | Last revision 2017-01-19 | URL: https://www.eptis.bam.de/pts288072 https://www.eptis.bam.de/pts288072

PT provider
PT provider GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology) GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology)
Based in Spain
Language(s) Spanish
Remarks
Keywords
Product groups Health care / medical devices
Human test material
Laboratory / scientific equipment
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human serum Anti TNF antibodies -
-
Anti infliximab antibodies -
-
Anti adalimumab antibodies -
Anti etanercept antibodies -
Infliximab level -
Adalimumab level -
Etanercept level -
Aims of the PT scheme
Target group of participants Immunology, Clinical analysis. Spain, Europe, South America
Linked to specific legislation / standards Regarding ISO guidelines
Additional, subsidiary aims
Number of participants Unknown
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by Spanish Society for Immunology
Fees and frequency
Participation fee EU 275
Regularly operated Yes (Twice a year)
Year of first operation 2017
Contact details of the PT provider
Provider Contact person
GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology)
Pº de Filipinos s/n
47007 Valladolid
Spain

Phone: +34 983 41 88 23 Ext.89673
Fax:
Web: https://www.geclid.es https://www.geclid.es
Dr. Carmen Martin
Phone: +34 686 247 331
Fax:
Email: responsable@geclid.es responsable@geclid.es
If you find any mistakes please contact the responsible EPTIS coordinator in Spain, Mr Miquel Navarro. Mr Miquel Navarro.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21